Why every healthcare breakthrough creates a new education challenge
Approval is not the same as adoption. A healthcare breakthrough may be supported by compelling evidence and formally recommended for use, but patients will only benefit if healthcare professionals and the systems around them are able to put it into practice.
Bridging that gap requires education that helps clinicians understand not only the innovation itself, but also its scope, what must change, and how they can help move implementation forward.
Why evidence doesn’t translate into access
Mechanical thrombectomy illustrates this. In 2015, a series of trials established the treatment as highly effective for certain patients experiencing an acute ischaemic stroke. By physically removing the clot, the procedure can dramatically reduce the likelihood of severe, lifelong disability – just one of the reasons NICE has been formally recommending it for eligible patients since 2019.
More than a decade after the evidence was established, however, the treatment is yet to become universally accessible. Recent research found that around 4.5% of UK stroke patients receive a thrombectomy, despite approximately 10% potentially being eligible. Access also varies considerably by region, with just over half of the UK’s comprehensive stroke centres providing the service around the clock. This stands in stark contrast to the NHS’s original aim of achieving full 24/7 provision by 2022.
The difficulty is that delivery requires far more than individual clinicians knowing the procedure works. It depends on rapid stroke recognition, specialist imaging, effective referral and transfer pathways, appropriately trained teams, and continuous access to specialist facilities. A clinician might understand exactly what the evidence recommends while working within a system that cannot yet provide it.
Every new healthcare breakthrough creates its own version of this challenge. Publishing evidence and securing approval are only the first steps. The people expected to use new recommendations and innovations in real-world practice need knowledge to enable them to do so. That’s why healthcare education itself must evolve.
From informed clinicians to influential advocates
Independent, impact-focused medical education can help clinicians move beyond being passive recipients of information waiting for the wider system to move forward. Rather than simply presenting new evidence in a lecture hall or classroom, it can prepare them to become informed advocates for change in practice.
When healthcare professionals understand the strength of emerging evidence; the patients most likely to benefit; and the practical barriers to adoption that might stand in their way, they become far better equipped to ask the right questions, strengthen business cases, and contribute meaningfully to the redesign of clinical pathways. They don’t just digest new information, but actively learn to recognise eligible patients, make appropriate referrals, and prepare for implementation before an innovation becomes routine locally. This is significant because progress rarely happens via a single national decision. It depends on people throughout the entire healthcare system understanding why change is needed and how to introduce it safely.
Education’s purpose is not to suggest that clinicians implement every breakthrough immediately or independently, but instead to give them the confidence and capability needed to be able to influence what happens next.
One discovery, dozens of decisions
Even apparently straightforward innovations can generate multiple clinical questions. In July 2024, for instance, NICE recommended CYP2C19 genotype testing to assess whether clopidogrel is suitable for people who have recently experienced an ischaemic stroke or transient ischaemic attack. Some people carry genetic variants that prevent the drug from working as effectively, meaning an alternative treatment may offer better protection against another stroke.
Turning that recommendation into routine care is not as simple as telling clinicians that the test exists. Healthcare systems must also decide who orders testing, where samples will be processed, how quickly results are returned, who interprets them, and how prescribing decisions will be communicated. Clinicians must also be able to explain the test and its implications to patients, consider differences across ethnic groups, and know what to do when testing is unavailable or results are delayed. This requires confident decision making – a capability that cannot be developed through passive instruction alone.
NICE itself acknowledges that capacity must be developed gradually in order to implement laboratory testing at the scale required. NHS Tayside began testing within its acute stroke service in 2022 via a pilot scheme initially covering an estimated 600 to 800 patients annually, proving that, although the evidence may produce a recommendation, implementation hinges on dozens of decisions.
A full room can still mean an empty promise
Organisations investing in independent medical education must take this on board. It’s tempting to measure success using registration numbers, attendance figures, completion rates, and satisfaction scores – as has long been the standard. However, these numbers can only demonstrate reach, failing to show whether or not learners actually become better prepared to respond to a breakthrough in practice.
Successful programmes must therefore begin by identifying the obstacles preventing real-world progress. Perhaps clinicians remain unaware of the evidence or feel uncertain about patient selection. Low confidence may be preventing accurate interpretation of results, while unclear professional responsibilities may be holding people back from implementing change. Whatever the barrier, learning must be built around it.
Evidence gaps may require expert interpretation, while confidence gaps may be better addressed through case-based learning. Similarly, capability gaps can call for simulation or decision-making practice, with pathway barriers calling for multidisciplinary education that involves everyone responsible for delivering change.
Evaluation must follow the same logic. Rather than asking whether learners attended or enjoyed a programme, providers should be asking whether it improved their understanding, confidence, decision-making skills, and preparedness to act or advocate.
Designed well, independent medical education bridges the gap between discovery and delivery. It does more than just announcing what has changed – helping healthcare professionals to understand what that change means in the reality of patient care and equipping them to move things forward responsibly.
About the author
Emily Harrison is managing director of Nexus Healthcare Education.
